Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1)

John R. Benson, Ismail Jatoi

Research output: Contribution to journalArticlepeer-review

Abstract

The 40th annual San Antonio Breast Cancer Symposium was convened in San Antonio, TX, USA on 5-9 December 2017. More than 7500 clinicians and scientists from around the world participated in the symposium which featured a range of presentations and keynote talks pertaining to breast cancer screening, prevention, loco-regional and systemic therapies. This two-part report highlights a selection of important studies presented at this premier breast cancer event with part 1 focusing on dose-intense radiotherapy, perioperative endocrine therapy, duration of bisphosphonates, immunotherapy, ovarian function suppression and acupuncture. The second part of this report will discuss a range of topics related to de-escalation of loco-regional therapies, the significance of complete pathological response, older patients and CDK 4/6 inhibitors, circulating tumor cells and plasma DNA as a tumor marker.

Original languageEnglish (US)
Pages (from-to)1889-1892
Number of pages4
JournalFuture Oncology
Volume14
Issue number19
DOIs
StatePublished - Aug 2018

Keywords

  • San Antonio
  • breast conserving surgery
  • ductal carcinoma in situ
  • immunotherapy
  • neoadjuvant
  • ovarian suppression
  • radiation treatment
  • sentinel node

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint Dive into the research topics of 'Tailoring breast cancer therapies to reduce mortality and improve quality of life: San Antonio Breast Cancer Symposium 2017 (part 1)'. Together they form a unique fingerprint.

Cite this